Policy & Regulation
Beckman Coulter Life Sciences' RNA extraction kit ready for use in EUA authorized COVID-19 test
29 May 2020 -

Life science company Beckman Coulter Life Sciences stated on Thursday that its RNA extraction kit, RNAdvance Viral XP, has been included on the list of acceptable extraction methods for use in the Centers for Disease Control's EUA-authorized COVID-19 test referenced in the FDA's FAQ on testing for SARS-CoV-2.

The company explained that the extraction of RNA from viral samples is a critical step for pathogen research and detection to enable accurate downstream assay results. Laboratories are now permitted to independently validate RNAdvance Viral XP for use.

Earlier this month the company formally launched RNAdvance Viral XP as a reagent kit for research use.

Login
Username:

Password: